Our Services
Medical Information
Helpful Resources
Published on: 4/23/2026
Photobiomodulation (red light therapy) is a non-invasive supportive approach that early animal and small human studies suggest can reduce Parkinson’s tremors and improve coordination, mood, and sleep by boosting mitochondrial function, reducing oxidative stress, and calming inflammation. Side effects are rare and mild, but large clinical trials are needed to confirm optimal wavelengths, dosing regimens, and long term benefits.
See below for guidance on device selection, treatment protocols, and safe integration with your current Parkinson’s management plan.
Photobiomodulation (PBM), often referred to as red light therapy, is gaining attention as a potential supportive therapy for Parkinson's disease (PD). While it's not a cure, early research suggests it may help manage certain symptoms—especially tremors—by targeting mitochondria, reducing inflammation, and promoting cellular health.
Parkinson's is a progressive neurological condition marked by:
These symptoms arise from the loss of dopaminergic neurons in the brain's substantia nigra. Conventional treatments include medications like levodopa and deep brain stimulation, but side effects and diminishing benefits over time drive patients and researchers to explore complementary options.
Photobiomodulation, or red light therapy, involves exposing cells or tissues to low-level red or near-infrared (NIR) light (wavelengths roughly 600–1000 nm). Key characteristics:
In the context of Parkinson's, the term "red light therapy for Parkinson's tremor management" refers to applying this light to the head or specific body regions to influence neural and muscular function.
Research into red and NIR light's effects on neurons is ongoing, but several mechanisms may explain potential benefits:
Improved mitochondrial function
Reduced oxidative stress
Anti-inflammatory effects
Enhanced blood flow
Collectively, these actions could help stabilize neuronal circuits involved in movement control and reduce the severity of tremors.
Although most studies are preliminary, several findings are encouraging:
Animal studies
Rodent models of Parkinson's show that NIR light to the skull can preserve dopaminergic neurons and improve motor function.
Small human trials
Safety profile
Adverse events are rare. Some users report mild warmth or tingling at the treatment site, but serious side effects are virtually unheard of in the studied dose ranges.
Despite these positive signals, large, randomized controlled trials are still needed to confirm efficacy, optimal dosing (wavelength, intensity, duration), and long-term effects.
If you're curious about using photobiomodulation for Parkinson's tremor management, keep these points in mind:
Consult your healthcare team
Always discuss new therapies with your neurologist or primary care doctor, especially if you're on medications or have other health conditions.
Choose the right device
Establish a treatment plan
Monitor your symptoms
Keep a journal or use an app to track tremor severity, stiffness, sleep quality, and mood. Notes will help you and your doctor assess whether the therapy is making a difference.
Benefits
Limitations
Photobiomodulation may work best when combined with proven Parkinson's management strategies:
Some people find it helpful to start with a structured assessment:
Before beginning any new treatment approach, it's important to understand your current symptom profile—a quick, free AI-powered Parkinson's Disease symptom checker can help you identify patterns and prepare better questions for your next doctor's visit.
While red light therapy for Parkinson's tremor management holds promise, it remains an emerging field. Early studies encourage continued exploration, but larger clinical trials are essential to:
If you're intrigued by photobiomodulation, talk it over with your healthcare team. They can help you weigh the pros and cons, integrate sessions into your overall care plan, and monitor your response.
Remember, nothing replaces professional medical advice. Always speak to a doctor if you experience worsening symptoms or anything that could be life-threatening or serious.
(References)
* Huang Y, Chen X, He H, Wu G, He B, Li D, Zhu S. Transcranial photobiomodulation in Parkinson's disease: a critical review. Front Aging Neurosci. 2023 Mar 24;15:1159842. doi: 10.3389/fnagi.2023.1159842. PMID: 37025178; PMCID: PMC10079946.
* Hamblin MR. Photobiomodulation in Parkinson's Disease: A Review of Efficacy and Mechanisms. Int J Mol Sci. 2022 Oct 26;23(21):12918. doi: 10.3390/ijms232112918. PMID: 36297375; PMCID: PMC9658257.
* Johnstone DM, Moro C, Stone J, van der Meer L, Mitrofanis J, El Massri N. Transcranial photobiomodulation for Parkinson's disease: What do we know, what do we not know and what should we do? Ageing Res Rev. 2022 Aug;80:101683. doi: 10.1016/j.arr.2022.101683. Epub 2022 May 21. PMID: 35728347.
* Virk S, Moro C, Stone J, El Massri N, Johnstone DM. Photobiomodulation and Parkinson's disease: a systematic review of current evidence. Front Neurol. 2020 Jan 21;10:1406. doi: 10.3389/fneur.2019.01406. PMID: 32014781; PMCID: PMC6985440.
* Liebert A, Bicknell B, Stone J, Johnstone D, Mackin M, Barnett M, Mitrofanis J, Wyss-Coray T, El Massri N. Transcranial photobiomodulation improves cognition and motor function in Parkinson's disease: a pilot study. J Photochem Photobiol B. 2019 Feb;191:124-129. doi: 10.1016/j.jphotobiol.2019.01.006. Epub 2019 Jan 10. PMID: 30743603.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.